All Q2 FY27 results →
GH

Global Health Ltd

Q2 FY27Healthcare Services

Global Health Q2 Results 2026 (FY27) investor presentation: Revenue & Margins

Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.

Price₹1,298
Market cap₹34.9K Cr
P/E61.0
Updated3 Nov 2026
Read3 min read

Global Health Ltd Q2 FY27 key numbers

Revenue
Q2 FY2027 revenue from operations: INR 14,690 million, up 33.6% year-on-year (YoY).

As stated in Global Health Ltd's Q2 FY27 investor presentation · published 3 Nov 2026. Reported figures, not investment advice.

Based on Global Health Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

The short version

Q2 FY2027 revenue from operations: INR 14,690 million, up 33.6% year-on-year (YoY). Q2 FY2027 Operating EBITDA: INR 3,701 million, up 60.2% y-o-y (Q2 FY2026: INR 2,310 million)

From Global Health Ltd's Q2 FY27 earnings-call transcript · updated 3 Nov 2026.

How did Global Health's revenue grow in the September 2026 quarter?

  • Q2 FY2027 revenue from operations: INR 14,690 million, up 33.6% year-on-year (YoY).
  • Operating EBITDA for Q2 FY2027: INR 3,701 million, +60.2% YoY with margin at 25.2% vs. 21.0%.
  • Profit After Tax (PAT) for Q2 FY2027: INR 2,191 million, +38.3% YoY, PAT margin 14.9%.
  • In-patient volumes: 65,956 in Q2 FY2027, +29.5% YoY.
  • Out-patient volumes: 1,228,614 in Q2 FY2027, +37.9% YoY.
  • Census bed capacity increased to 3,115 beds in Q2 FY2027 from 2,658 beds (+17%).
  • Occupied bed days: 190,600 in Q2 FY2027, +22.4% YoY with ~67% occupancy.

2 more points from Global Health Ltd's call on revenue

Create a free account to keep reading this call

What happened to Global Health's margins in Q2 FY27?

See what Global Health Ltd said on profitability & margins — free account, 30 seconds.

What capex is Global Health planning?

  • Total planned capex of ~INR 62,390 million over 4-5 years, including maintenance capex of INR 11,000 million (Page 19).
  • Key projects with allocated capex:
  • Lucknow, Patna, Noida, Ranchi: INR 12,175 million
  • South Delhi-DLF: INR 3,424 million
  • Mumbai Pitampura, Delhi: INR 5,398 million
  • Guwahati: INR 8,986 million
  • Varanasi: INR 5,898 million
  • Indore Cancer Unit: INR 9,820 million
  • Ghaziabad (500-bed hospital): INR 3,385 million
  • Medical School: INR 6,000 million
  • Guest House: INR 425 million (Page 19).
  • Bed capacity expansion:
  • Total beds added ~20% in FY26
  • H1 FY27 additions: Lucknow (46 beds, total 803), Noida (100 beds, total 482), Indore Cancer Unit (80 beds, expected Q3 FY27)
  • Announced new campuses with beds: South Delhi (400 beds), Mumbai, Guwahati, Varanasi (400 beds), Ghaziabad (500 beds)
  • Status:
  • Bangalore ongoing construction (Piling started, environmental clearances done)
  • Guwahati land acquired and approvals secured
  • Varanasi building plans submitted
  • Ghaziabad land allotted via e-auction

2 more points from Global Health Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 2
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Is Global Health raising money or cutting debt?

See what Global Health Ltd said on fundraising & capital structure — free account, 30 seconds.

How big is Global Health's order book?

It includes definitions, quarterly and half-year financial results, hospital operations, and growth highlights but contains no references to order books or order inflows.

Global Health Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹1.5K Cr, net profit ₹219 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Services this season

  • Vijaya Diagnostic Centre (Q2 FY27)

    Q2 FY27 Revenue from Operations: INR 2,554 Mn, up 26.7% YoY (Page 10, 9) . Key investor presentation takeaways from Vijaya Diagnostic Centre Ltd's Q2 FY27 inves

  • Shalby (Q2 FY27)

    Consolidated Total Revenue for Q2 FY27: ₹3,182 million vs ₹2,899 million in Q2 FY26, up 9.8% YoY (Pages 5, 6, 8, 9) . Key investor presentation takeaways from S

  • Metropolis Healt (Q2 FY27)

    Q2FY27 revenue from operations: INR 496.8 Cr, up 15.8% YoY (Page 11) . Key investor presentation takeaways from Metropolis Healthcare Ltd's Q2 FY27 investor pre

  • Nephrocare Health Services (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹303.4 Cr, up 23.5% YoY from ₹245.7 Cr in Q2 FY26 (Page 9). Key investor presentation takeaways from Nephrocare Health Services

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Global Health Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Global Health Ltd Q2 FY27 results?

Q2 FY2027 revenue from operations: INR 14,690 million, up 33.6% year-on-year (YoY). Q2 FY2027 Operating EBITDA: INR 3,701 million, up 60.2% y-o-y (Q2 FY2026: INR 2,310 million)

What is Global Health Ltd share price analysis?

Global Health Ltd currently shows a neutral. The stock trades at a P/E of 61.0 with a market cap of ₹34,911 Cr. Investors should review the full earnings analysis for detailed insights.

Is Global Health Ltd planning capital expenditure?

Total planned capex of ~INR 62,390 million over 4-5 years, including maintenance capex of INR 11,000 million (Page 19).

Keep Global Health Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.